| Doherty, Elizabeth (Novartis 201602– Board Director PROPOSED) |
Board member, non-executive |
Novartis (Group) |
Switzerland |
| Eastham, Karin (Board Director at MorphoSys + Illumina + Amylin + Trius + Geron) |
Board member, non-executive |
Personalis (Group) |
United States (USA) |
| Ebsworth, David (Galenica 200910–201508 CEO Vifor Pharma RETIRES 8/14 before OGS CEO + Bayer Head Pharma |
Board member, non-executive |
Verona Pharma (Group) |
United Kingdom (GB) |
| Edwards, Tim (Cellzome 200507 CEO) |
Board member, non-executive |
GSK (Group) |
Germany |
| Ernst, Bettina (Bernina BioInvest 202011 Director + InterAx Biotech 201901– Non-executive Board Member) |
Board member, non-executive |
Bernina BioInvest AG |
Switzerland |
| Fellner, Peter (Acambis 200703 President) |
Board member, non-executive |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
| Firmenich, Patrick (Firmenich 202205 Chairman) |
Board member, non-executive |
Firmenich (Group) |
Switzerland |
| Franz, Christoph (Roche 201403– Board Chairman before Lufthansa CEO) |
Board member, non-executive |
Roche (Group) |
Switzerland |
| Friedman, Paul A. (Incyte 201401 non-executive Board Member before CEO) |
Board member, non-executive |
Incyte Corporation (Group) |
United States (USA) |
| Fudge, Ann |
Board member, non-executive |
Novartis (Group) |
Switzerland |
| Gertsch, Martin (Santhera 201501 Non-executive Chairman of the Board) |
Board member, non-executive |
Santhera (Group) |
Switzerland |
| Giuliani, Germano (Board Member 202003 at ElevateBio + HBM + Royalty Pharma formerly CFO+CEO of Giulian SpA) |
Board member, non-executive |
ElevateBio (Group) |
United States (USA) |
| Hacke, Werner (Lion 200603) |
Board member, non-executive |
2invest (Group) |
Germany |
| Hecht, Thomas (Delenex 201105 Board Chairman + Affimed 201112 Board Chairman) |
Board member, non-executive |
Athenex (Group) |
Switzerland |
| Hoffmann, André (Roche 202404 Non-Executive Vice-Chairman of the Board of Directors |
Board member, non-executive |
Roche (Group) |
Switzerland |
| Humer, Franz B. (Roche –2014 non-exec Chairman before CEO) |
Board member, non-executive |
Roche (Group) |
Switzerland |
| Karabelas, Jerry (Polyphor 201503 Board Chairman) |
Board member, non-executive |
Spexis (Group) |
Switzerland |
| Kay, Andrew (NuCana 202012– Board Chairman also at Boards of NeRRe Tx + Blueberry Tx former CEO of Algeta) |
Board member, non-executive |
NuCana plc (Nasdaq: NCNA) |
United Kingdom (GB) |
| Kiener, Peter A. (Sucampo + Ambrx + Zyngenia + MedImmune) |
Board member, non-executive |
Mallinckrodt (Group) |
United States (USA) |
| Krautscheid, Oliver (Mologen 201603 Supervisory Board Chairman) |
Board member, non-executive |
Mologen (Group) |
Germany |
| Köstlin, Ulrich (Newron 2013– Board Chairman before until 2011 Management Board Member of Bayer Schering Pharma AG) |
Board member, non-executive |
Newron (Group) |
Italy |
| Lamottke, Maria (Bicoll 202211) |
Board member, non-executive |
Bicoll (Group) |
China |
| Laukien, Jörg C. (Bruker –201811 Board Member RETIRED 11/18) |
Board member, non-executive |
Bruker (Group) |
United States (USA) |
| Lifton, Richard P. (Roche 201503– Board Member) |
Board member, non-executive |
Roche (Group) |
Switzerland |
| Luria, Xavier (AMP BIosimilars 201504 Scientific Board Member + former Head of Medicines Safety + Efficacy at EMA) |
Board member, non-executive |
AMP Biosimilars AG |
Germany |
| Machielse, Ben (Mosanna Therapeutics 202207 Board Chair before Vtesse + Omthera Pharmaceuticals) |
Board member, non-executive |
Mosanna Therapeutics AG |
Switzerland |
| Marshak, Daniel R. (Tecan 201710– Board proposed before PerkinElmer + Cambrex) |
Board member, non-executive |
Tecan (Group) |
Switzerland |
| Martin, Keith (Apitope 201810 Non-Executive Director before 2006–201810 CEO RETIRED 10/18) |
Board member, non-executive |
Apitope (Group) |
United Kingdom (GB) |
| Matheis, Georg (Stimit AG 202104 Board Director) |
Board member, non-executive |
Dräger (Group) |
Switzerland |
| Meier, Thomas (Viopas Venture Consulting 202201 Managing Partner before Santhera Pharmaceuticals) |
Board member, non-executive |
Viopas Venture Consulting (VVC) (Group) |
Switzerland |
| Michel, Willy (Finox AG 201310 majority shareholder + Board President) |
Board member, non-executive |
Finox AG (Finox Biotech) |
Switzerland |
| Mouney, Jean-François (Genfit 201909– Board Chairman before 1999–201909 CEO + Co-Founder) |
Board member, non-executive |
Genfit (Group) |
France |
| Mueller, André J. (Addex 201106 Chairman of the Board before Actelion CFO before Biogen before Sandoz) |
Board member, non-executive |
Addex (Group) |
Switzerland |
| Mäder, Christoph (Lonza 202404 Lead Independent Director + Vice Chair) |
Board member, non-executive |
Lonza (Group) |
Switzerland |
| Möller, Gerald (HBM Bio Ventures 201007 Advisor former Roche + Boehringer Mannheim CEO 1995–1997) |
Board member, non-executive |
HBM (Group) |
Germany |
| Nakamoto, Akira (Shimadzu 201504– Board Chairma before CEO) |
Board member, non-executive |
Shimadzu (Group) |
Japan |
| Nash, Duane (Immunic 202207 Board Chair) |
Board member, non-executive |
Immunic (Group) |
United States (USA) |
| Noble, James (Adaptimmune 201909– Non-Executive Director before CEO before MediGene + Avidex) |
Board member, non-executive |
Adaptimmune (Group) |
United Kingdom (GB) |
| Novak, Rodger (CRISPR Therapeutics 201712– Board Chairman 2013–201711 CEO + Co-Founder before Sanofi + Nabriva GmbH) |
Board member, non-executive |
CRISPR Therapeutics (Group) |
Switzerland |
| Ornell, John (Bruker 201508– Board Director before Waters 2001–2013 CFO RETIRED 2014) |
Board member, non-executive |
Bruker (Group) |
United States (USA) |
| Ottenberg, Karsten (AATec Medical 202307 Board Chair + Co-Founder) |
Board member, non-executive |
AATec Medical GmbH |
Germany |
| Overesch, Erich (OHB-System 200902 Head of Supervisory Board) |
Board member, non-executive |
Fuchs (Group) |
Germany |
| O’Neill, Julie (Hookipa 201811– non-exec Board Member as well as at DBV Technologies before Alexion + Gilead) |
Board member, non-executive |
Hookipa (Group) |
United States (USA) |
| O’Riordan, Paul (Synexa Life Sciences 202205 Chairman) |
Board member, non-executive |
Synexa Life Sciences (Group) |
Finland |
| Pisa, Eva (Qiagen 202206– Supervisory Board Member formerly Roche Diagnostics + Sangtec Molecular Diagnostics) |
Board member, non-executive |
Qiagen (Group) |
Netherlands |
| Plückthun, Andreas (Univ Zurich 200605) |
Board member, non-executive |
University of Zurich (UZH) |
Switzerland |
| Prieels, Jean-Paul (Themis Bioscience 201505– Board Member former SVP RnD at GSK Biologicals) |
Board member, non-executive |
Merck (US) (MSD) (Group) |
Austria |
| Rataj, Sue H. (Agilent 201509– Non-exec Board Member + Bayer 201204– Supervisory Board Member before BP retired 4/11) |
Board member, non-executive |
Agilent (Group) |
United States (USA) |
| Reinhardt, Jörg (Novartis 201308– Board Chairman before Bayer 201008– CEO Bayer HealthCare AG before Novartis COO) |
Board member, non-executive |
Novartis (Group) |
Switzerland |
| Riley, Jeffrey (Gain Therapeutics 201909– Independent Board Director formerly SKB + Pfizer + Queensland Biocapital Fund) |
Board member, non-executive |
Gain Therapeutics (Group) |
Switzerland |
| Rocci, Mario (Solvias 202203 Chair + Advisor Water Street Healthcare Partners) |
Board member, non-executive |
Solvias (Group) |
Switzerland |
| Ryals, John (Metabolon 201806– Board Director before CEO + Co-Founder) |
Board member, non-executive |
Metabolon (Group) |
United States (USA) |
| Said, Maya (Transgene 201706– Non-Executive Board Member before Novartis + Sanofi + Boston Consulting) |
Board member, non-executive |
Mérieux (Group) |
France |
| Sand, Roland (Glycotope 201601 Board Chairman) |
Board member, non-executive |
Glycotope (Group) |
Germany |
| Sandor, Victor (ADC Therapeutics 202004– Board Director before CMO at Array BioPharma + Incyte + Biogen Idec + AZ) |
Board member, non-executive |
ADC Therapeutics (Group) |
Switzerland |
| Sanghera, Jas (TTP Labtech 201606– Chairman before Managing Director + Commercial Director + Co-founder) |
Board member, non-executive |
SPT Labtech (Group) |
United Kingdom (GB) |
| Sato, Vicki (Harvard Univ 2001104 Prof + Atlas Venture Business Adivisor before Vertex President + CSO before Biogen) |
Board member, non-executive |
Harvard University |
United States (USA) |
| Schatz, Peer M. (Resolve BioSciences 202012 Chairman + Co-Founder before Qiagen 1993–201910 CEO RESIGNED 10/19) |
Board member, non-executive |
PS Capital Management GmbH (Peer Schatz) |
Germany |
| Schneider, Manfred (Bayer) |
Board member, non-executive |
Bayer (Group) |
Germany |
| Scholz, Bernhard (Xlife Sciences 202201 Board Chair) |
Board member, non-executive |
Xlife Sciences AG (SIX: XLS) |
Switzerland |
| Scodari, Joseph C. (Actelion –201107 Board Director RESIGNED 8/11) |
Board member, non-executive |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
| Selvaraju, Raghuram (Ram) (Relief Therapeutics 202010 Board Chairman) |
Board member, non-executive |
Relief Therapeutics (Group) |
Switzerland |
| Stuge, Örn (Aleva Neurotherapeutics 201108 Chairmen Board of Directors) |
Board member, non-executive |
Aleva Neurotherapeutics S.A. |
Switzerland |
| Valente, Nancy (Immatics 202203– Non-executive Board Director formerly at Genentech/Roche) |
Board member, non-executive |
Immatics (Group) |
Netherlands |
| Vasella, Daniel (Novartis CEO 199612–201001 after 1/10 continues as Chairman) |
Board member, non-executive |
Numab (Group) |
Switzerland |
| Velasco, Martin (AC Immune 201401 Board Chairman) |
Board member, non-executive |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Verrelst, Herman (Biocartis 202304– Board Chair before CEO before Agilent + Cartagenia + Medicim + Data4s) |
Board member, non-executive |
Biocartis (Group) |
Belgium |
| Weilermann, Wolfgang (NascaCell 200809 Chairman Supervisory Board) |
Board member, non-executive |
NascaCell (Group) |
Germany |
| Weinberg, Serge (Sanofi 201906 Board Chairman) |
Board member, non-executive |
Sanofi (Group) [since May 2011] |
France |
| Werner, Thomas (Board Member of several companies before GSK SVP) |
Board member, non-executive |
GSK (Group) |
United Kingdom (GB) |
| Wills, Robert J. (Rob) (at JnJ 25 years before Roche) |
Board member, non-executive |
Johnson & Johnson (JnJ) (Group) |
United States (USA) |
| Adomat, Jens (Analytik Jena 1990–201312 Deputy Chairman of Executive Management Board + Co-founder LEFT 12/13) |
Board member, executive |
Endress+Hauser (Group) |
Germany |
| Ahlers, Benedikt (Florenus AG 200912– Executive Director + Founder before IP Bewertungs AG Head Sales + Developm) |
Board member, executive |
Florenus AG |
Germany |
| Amberger, Christoph (KWS 201207 Executive Board Member responsible for corn) |
Board member, executive |
KWS Saat (Group) |
Germany |
| Ammer, Richard (Medice Pharma 201704 Executive Board Member) |
Board member, executive |
Medice (Group) |
Germany |
| Arnold, Matthias (DASGIP AG 201201 CEO) |
Board member, executive |
Eppendorf (Group) |
Germany |
| Baerlocher, Urs (Novartis –200708) |
Board member, executive |
Novartis (Group) |
Switzerland |
| Beckmann, Kai (Merck KGaA 201709– Executive Board Member for Performance Materisl before Human Resources) |
Board member, executive |
Merck (DE) (Group) |
Germany |
| Björgólfsson, Thor (Novator Partners 2004– Chairman + Founder) |
Board member, executive |
Novator Partners (Group) |
United Kingdom (GB) |
| Breiner, Klaus (BB Biotech Ventures + Vaximm 201605 Executive Chairman) |
Board member, executive |
Vaximm (Group) |
Switzerland |
| Brown, Stephanie (Santhera 202112– President North America + Executive Board Member before Ipsen US + Novartis US) |
Board member, executive |
Santhera (Group) |
United States (USA) |
| Büntemeyer, Heino (TeutoCell 201105 Executive Board Member) |
Board member, executive |
Xell AG |
Germany |
| Drejer, Kirsten (Symphogen 2000–201608 Founding CEO since 201609 Executive Director) |
Board member, executive |
Servier (Group) |
Denmark |
| Dubourg, Saori (BASF 201909 Executive Board Director) |
Board member, executive |
BASF (Group) |
Germany |
| Duvall, Jean (Ferring 201912 Executive Board Member of Ferring Pharmaceuticals + Co-Chair of FerGene) |
Board member, executive |
Ferring (Paulsen Foundation) (Group) |
Switzerland |
| Fuchs, Marco R. (OHB-System 200902 Executive Board Director) |
Board member, executive |
Fuchs (Group) |
Germany |
| Gaissmaier, Christoph (B Braun 201307 Executive Manager) |
Board member, executive |
B. Braun (Group) |
Germany |
| Gladwell, Mark (Qiagen 201710c– SVP Global Operations before Alere Inc) |
Board member, executive |
Qiagen (Group) |
Germany |
| Goddard, Colin (FoRx Therapeutics 202004– Executive Chairman former CEO of OSI Pharmaceuticals) |
Board member, executive |
FoRx Therapeutics AG |
Switzerland |
| Gruchow, Andreas (Deutsche Messe 201705 Member of Managing Board) |
Board member, executive |
Deutsche Messe AG |
Germany |
| Habashita, Hiromu (Ono Pharmaceutical 201703 Corp Officer + Executive Director Discovery + Research) |
Board member, executive |
Ono Pharmaceutical (Group) |
Japan |
| Hasselmann, Harald (Eckert & Ziegler 202306– promoted to Executive Director & Board Chair) |
Board member, executive |
Eckert & Ziegler (Group) |
Germany |
| Hengster, Ingrid (Germany (govt) 201505 Exective Board Member of KfW) |
Board member, executive |
Germany (govt) |
Germany |
| Hermann, Ralf (Eppendorf –201610 Chief Marketing + Portfolio Manager LEFT 10/16 before Sartorius/Vivascience + Qiagen) |
Board member, executive |
Eppendorf (Group) |
Germany |
| Hoch, Thomas (EVP Capital 201106 Executive Board Director) |
Board member, executive |
EVP Capital Management AG |
Germany |
| Hoffmann, Axel-Rainer (Volkswohl Bund 202012 Board Member) |
Board member, executive |
Volkswohl Bund (Group) |
Germany |
| Jagiella, Manfred (Endress+Hauser 201711 Group Board Member responsible for analytical business) |
Board member, executive |
Endress+Hauser (Group) |
|
| Jansen, Sven (Noventi 202202 Executive Board Member) |
Board member, executive |
Noventi (Group) |
Germany |
| Janssen, Egbert (Celsius79.com AG 201212 Vorstand) |
Board member, executive |
Celsius37.com AG |
Germany |
| Jung, Christian Billy (Dementia Discovery Fund 202106 Partner formerly HTGF 201305 Investment Manager) |
Board member, executive |
SV Health Investors (Group) |
United Kingdom (GB) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 88 89 90 91 
Position
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
